ArticleBMC public health2026
Navigating the kidney disease care cascade in type 2 diabetes: insights from the national diabetes registry.
Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDiabetic kidney disease (DKD) is a common complication among people with type 2 diabetes (T2D) and is a leading cause of chronic kidney disease (CKD). Malaysia ranks among the highest diabetes-related CKD rates worldwide, and despite research emphasis on diabetes and its complications, the unmet needs for DKD care remain largely unexplored. This study aimed to identify the unmet need for diagnosis, treatment, and control of DKD using the care cascade among patients with T2D receiving follow-up care in government health clinics in Malaysia.
methodsA cross-sectional analysis of the National Diabetes Registry (NDR) 2023 was conducted. Inclusion criteria were adult patients with T2D that received DKD screening or had a diagnosis of nephropathy. DKD was defined as either documented nephropathy in the NDR, or abnormal estimated glomerular filtration rate (eGFR) or albuminuria. Treatment was defined as the documented prescription of either angiotensin converting enzyme inhibitor (ACEi)/angiotensin-receptor blocker (ARB)/Sodium-glucose Cotransporter 2 inhibitors (SGLT2i)/ Glucagon-like peptide-1 receptor agonist (GLP1-RA) and statin, whereas control was defined as achieving glycosylated haemoglobin A1c (HbA1c) and blood pressure targets. Multivariable logistic regression was done to identify the determinants for unmet need at each stage.
resultsThe prevalence of DKD among diabetic patients was 53.2% (56949/107099). The prevalence of total unmet need for care was 97.6%, with deficiencies observed across all stages; diagnosis (74.6%), treatment (27.9%) and control (86.8%). The two crucial gaps identified in this care cascade were for uncontrolled and undiagnosed DKD, with uncontrolled blood pressure identified as the main contributor for uncontrolled DKD. Risk factors for unmet need were female sex (adjusted odds ratio (AOR) 1.23-1.39), middle age (AOR 1.38-3.15), and hyperlipidaemia (AOR 1.10-1.52).
conclusionsThe DKD care cascade identified a notable gap in meeting care needs, with a consistent deficiency in care at each stage. This study findings serve as a benchmark and framework for the evaluation and improvement of DKD care in Malaysia. While addressing the factors associated with undiagnosed and uncontrolled DKD are crucial, further evaluation of home-based blood pressure should be done prior to intensifying control measures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.